Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-28 Sale | 2023-11-30 5:41 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.7195 | $76,918 | 7,395,973 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 5:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $6.7599 | $20,280 | 1,681,536 (Direct) | View |
| 2023-11-15 Sale | 2023-11-17 5:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $6.51 | $117,180 | 832,610 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 6:55 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.3197 | $56,151 | 7,407,420 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 6:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $6.8186 | $340,929 | 4,549,416 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 6:14 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 62,177 | $5.1675 | $321,301 | 10,079,403 (Indirect Direct) | View |
| 2023-10-31 Sale | 2023-11-02 7:02 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $5.2745 | $46,864 | 7,416,305 (Direct) | View |
| 2023-10-26 Sale | 2023-10-30 6:26 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $5.6283 | $16,885 | 1,689,914 (Direct) | View |
| 2023-10-17 Sale | 2023-10-19 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.5822 | $58,483 | 7,425,190 (Direct) | View |
| 2023-10-16 Sale | 2023-10-18 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $6.3 | $113,400 | 854,213 (Direct) | View |
| 2023-10-10 Sale | 2023-10-12 6:07 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $6.9615 | $348,075 | 4,681,588 (Direct) | View |
| 2023-10-04 Sale | 2023-10-06 6:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 59,794 | $7.2085 | $431,025 | 10,141,580 (Indirect Direct) | View |
| 2023-10-03 Sale | 2023-10-05 6:25 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.2907 | $64,778 | 7,434,075 (Direct) | View |
| 2023-09-28 Sale | 2023-10-02 6:19 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $7.7198 | $23,159 | 1,692,914 (Direct) | View |
| 2023-09-19 Sale | 2023-09-21 6:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.3599 | $74,278 | 7,442,960 (Direct) | View |
| 2023-09-15 Sale | 2023-09-19 5:50 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $8.66 | $155,880 | 872,213 (Direct) | View |
| 2023-09-12 Sale | 2023-09-14 6:26 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $8.559 | $427,950 | 4,806,588 (Direct) | View |
| 2023-09-06 Sale | 2023-09-08 5:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 58,765 | $8.8053 | $517,442 | 10,211,374 (Indirect Direct) | View |
| 2023-09-05 Sale | 2023-09-07 7:02 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.7942 | $78,136 | 7,451,845 (Direct) | View |
| 2023-08-24 Sale | 2023-08-28 6:04 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $8.6561 | $25,968 | 1,695,914 (Direct) | View |
| 2023-08-22 Sale | 2023-08-24 5:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.9118 | $79,181 | 7,460,730 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 6:39 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $9.25 | $166,500 | 890,213 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 6:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $9.0862 | $454,310 | 4,969,088 (Direct) | View |
| 2023-08-08 Sale | 2023-08-10 5:33 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 17,770 | $11.16 | $198,283 | 7,469,615 (Direct) | View |
| 2023-08-02 Sale | 2023-08-04 5:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 65,015 | $13.04 | $847,712 | 10,297,052 (Indirect Direct) | View |
| 2023-07-27 Sale | 2023-07-28 5:50 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $13.62 | $108,994 | 1,704,292 (Direct) | View |
| 2023-07-25 Sale | 2023-07-27 6:31 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 40,000 | $14.36 | $574,200 | 1,401,285 (Direct) | View |
| 2023-07-25 Sale | 2023-07-27 6:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 18,719 | $14.61 | $273,464 | 7,487,385 (Direct) | View |
| 2023-07-18 Sale | 2023-07-19 7:07 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $14.58 | $729,150 | 4,246,494 (Direct) | View |
| 2023-07-17 Sale | 2023-07-19 7:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 60,000 | $12.73 | $763,800 | 1,491,285 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-16 Exercise | 2023-11-17 5:53 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $0 | 1,681,536 (Direct) | View |
| 2023-11-15 Tax Withholding | 2023-11-17 5:53 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 5,378 | $7.18 | 1,681,536 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-17 5:53 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $1.06 | 1,681,536 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:52 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $0 | 832,610 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $2.22 | 832,610 (Direct) | View |
| 2023-11-15 Tax Withholding | 2023-11-17 5:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 3,603 | $7.18 | 832,610 (Direct) | View |
| 2023-11-15 Conversion | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,052,490 (Direct) | View |
| 2023-11-15 Tax Withholding | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 16,913 | $7.18 | 10,052,490 (Direct) | View |
| 2023-11-15 Gift | 2023-11-17 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,052,490 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 6:54 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,549,416 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 6:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,549,416 (Direct) | View |
| 2023-11-15 Tax Withholding | 2023-11-16 6:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 7,172 | $7.18 | 4,549,416 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 6:14 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,079,403 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 6:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,079,403 (Direct) | View |
| 2023-11-01 Conversion | 2023-11-03 6:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,079,403 (Indirect) | View |
| 2023-10-26 Exercise | 2023-10-30 6:26 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $0 | 1,689,914 (Direct) | View |
| 2023-10-26 Exercise | 2023-10-30 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $1.06 | 1,689,914 (Direct) | View |
| 2023-10-16 Exercise | 2023-10-18 5:34 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $0 | 854,213 (Direct) | View |
| 2023-10-16 Exercise | 2023-10-18 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $2.22 | 854,213 (Direct) | View |
| 2023-10-16 Conversion | 2023-10-18 5:33 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,131,580 (Direct) | View |
| 2023-10-16 Gift | 2023-10-18 5:33 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,131,580 (Direct) | View |
| 2023-10-10 Exercise | 2023-10-12 6:07 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,681,588 (Direct) | View |
| 2023-10-10 Exercise | 2023-10-12 6:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,681,588 (Direct) | View |
| 2023-10-04 Exercise | 2023-10-06 6:12 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,141,580 (Direct) | View |
| 2023-10-04 Exercise | 2023-10-06 6:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,141,580 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 1,920 | $0 | 73,964 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:47 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director | 2,619 | $0 | 56,177 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:46 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 1,659 | $0 | 3,198,463 (Direct) | View |
| 2023-04-21 Gift | 2023-10-04 5:46 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 627,705 | $0 | 3,198,463 (Indirect) | View |
| 2023-09-28 Exercise | 2023-10-02 6:19 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $0 | 1,692,914 (Direct) | View |
| 2023-09-28 Exercise | 2023-10-02 6:19 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $1.06 | 1,692,914 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-19 5:50 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $0 | 872,213 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-19 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $2.22 | 872,213 (Direct) | View |
| 2023-09-15 Conversion | 2023-09-19 5:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,201,374 (Direct) | View |
| 2023-09-15 Gift | 2023-09-19 5:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,201,374 (Direct) | View |
| 2023-09-12 Exercise | 2023-09-14 6:26 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,806,588 (Direct) | View |
| 2023-09-12 Exercise | 2023-09-14 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,806,588 (Direct) | View |
| 2023-09-06 Exercise | 2023-09-08 5:01 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 10,211,374 (Direct) | View |
| 2023-09-06 Exercise | 2023-09-08 5:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,211,374 (Direct) | View |
| 2023-09-06 Conversion | 2023-09-08 5:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 10,211,374 (Indirect) | View |
| 2023-08-24 Exercise | 2023-08-28 6:04 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $0 | 1,695,914 (Direct) | View |
| 2023-08-24 Exercise | 2023-08-28 6:04 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 3,000 | $1.06 | 1,695,914 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 6:41 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 5,378 | $9.18 | 418,782 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 16,913 | $9.19 | 873,806 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:39 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $0 | 890,213 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $2.22 | 890,213 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 6:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 3,603 | $9.19 | 890,213 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:35 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,969,088 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:35 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,969,088 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 6:35 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 4,727 | $9.19 | 4,969,088 (Direct) | View |
| 2023-08-09 Conversion | 2023-08-11 4:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,326,976 (Direct) | View |
| 2023-08-09 Gift | 2023-08-11 4:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,326,976 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A 2032-02-04 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,924 | $0 | 10,297,052 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 8,674 | $11.4 | 10,297,052 (Direct) | View |
| 2023-08-02 Exercise | 2023-08-04 5:51 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,297,052 (Direct) | View |
| 2023-07-29 Exercise | 2023-07-28 5:50 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $0 | 1,704,292 (Direct) | View |
| 2023-07-27 Exercise | 2023-07-28 5:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $1.06 | 1,704,292 (Direct) | View |
| 2023-07-25 Exercise | 2023-07-27 6:31 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 40,000 | $0 | 1,401,285 (Direct) | View |
| 2023-07-25 Exercise | 2023-07-27 6:31 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 40,000 | $2.22 | 1,401,285 (Direct) | View |
| 2023-06-29 Gift | 2023-07-27 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 14,000 | $0 | 7,487,385 (Direct) | View |
| 2023-07-20 Conversion | 2023-07-21 5:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,362,067 (Direct) | View |
| 2023-07-20 Gift | 2023-07-21 5:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,362,067 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 7:07 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,246,494 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 7:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,246,494 (Direct) | View |
| 2023-07-17 Exercise | 2023-07-19 7:01 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 60,000 | $0 | 1,491,285 (Direct) | View |
| 2023-07-17 Exercise | 2023-07-19 7:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 60,000 | $2.22 | 1,491,285 (Direct) | View |